SYNSIGHT
  • BIENVENUE
    • A PROPOS
    • NOTRE EQUIPE
    • REJOIGNEZ NOUS !
  • APPROCHE
  • PIPELINE
  • PARTENARIAT AVEC SYNSIGHT
  • ACTUALITES
  • CONTACTS
Sélectionner une page

SYNSIGHT OBTIENT UN FINANCEMENT DE 1,5 MILLION DE DOLLARS POUR FAIRE PROGRESSER SA PLATEFORME TECHNOLOGIQUE DE DÉCOUVERTE DE MÉDICAMENTS ET ÉLARGIR SON PIPELINE [ENG]

par Anais MAX | Mar 29, 2022 | Communiqués de presse

DOWNLOAD THE PRESS RELEASE (.PDF) SYNSIGHT, a biotech company specialized in RNA-targeting small molecules drugs, today announce a $1.5 million fundraising. The financing was led by an international investor. SYNSIGHT is pleased to announce today a $1.5 million...

L’institut imagine et sinsight joignent leurs forces dans la recherche [ENG]

par Anais MAX | Déc 23, 2021 | Communiqués de presse

DOWNLOAD THE PRESS RELEASE (.PDF) Institut Imagine and SYNSIGHT are joining forces to develop research projects around innovative technological services in drug discovery. Institut Imagine and SYNSIGHT are joining their efforts and resources in joint research projects...

Synsight et MCule combine leur plateformes pour booster la recherche [ENG]

par Anais MAX | Déc 2, 2021 | Communiqués de presse

READ FULL PR Online PR News – 30-November-2021 – SYNSIGHT has a unique high-content screening platform powered by deep learning to discover and develop novel drugs primarily for RNA targets. SYNSIGHT has chosen Mcule to manage compound sourcing, storage,...

SIGNING OF A MEMORANDUM OF UNDERSTANDING BETWEEN SYNSIGHT AND BIOCUBATE TO DEVELOP AI DRUG DISCOVERY IN ASIAN MARKET [ENG]

par Anais MAX | Nov 29, 2021 | Communiqués de presse

DOWNLOAD THE PRESS RELEASE (.PDF) BIOCUBATE, a chinese base biotechnology company specializing in business development and incubation of bio-innovative projects, and SYNSIGHT, a french drug discovery company based on single-cell imaging and artificial intelligence...

Latest News

  • SYNSIGHT OBTIENT UN FINANCEMENT DE 1,5 MILLION DE DOLLARS POUR FAIRE PROGRESSER SA PLATEFORME TECHNOLOGIQUE DE DÉCOUVERTE DE MÉDICAMENTS ET ÉLARGIR SON PIPELINE [ENG]
  • L’institut imagine et sinsight joignent leurs forces dans la recherche [ENG]
  • NOUVELLE SELECTION IA POUR SYNSIGHT AVEC LE “TRUSTED AI START-UP” DECERNÉ PAR HUB FRANCE IA ET LA EUROPEAN AI STARTUP LANDSCAPE
  • Synsight et MCule combine leur plateformes pour booster la recherche [ENG]
  • SIGNING OF A MEMORANDUM OF UNDERSTANDING BETWEEN SYNSIGHT AND BIOCUBATE TO DEVELOP AI DRUG DISCOVERY IN ASIAN MARKET [ENG]

Archives

  • mars 2022
  • décembre 2021
  • novembre 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Enregistrer & accepter